The Lighthouse
Baltimore, Maryland, 21231, United States
NCT Number: NCT00218335
The purpose of this study is to evaluate a peer-based HIV prevention intervention that targets active injection drug users and their drug and sex partners.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Phase 2
Baltimore, Maryland, 21231, United States
HIV seroincidence among injection drug users remains high, with unprotected sexual contact substantially contributing to new HIV infections among injection drug users (IDUs). Interventions that are culturally competent and target drug users' main sex and drug partners may be especially effective for HIV/STI and HCV control and prevention.
The intervention to be tested in this study draws upon theoretical and empirical evidence suggesting that peer educator programs can have significant effects on the risk-related behaviors of both the educators and the peers whom they educate. Specifically, through group and individual focused sessions, participants learn and practice skills designed to reduce drug and sex related risk behaviors. Furthermore, individuals and their main risk partners attend a training session that focuses on risk reduction within their relationship.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
(i)Self reported injection drug use within the prior 6 months; (ii)Willingness to invite a risk network member into the study and to talk about HIV prevention; (iii)Age 18 or older
Exclusion criteria
In the intervention Condition participants were trained to be Health Educators. The intervention focused on HIV risk reduction by teaching knowledge and skills to reduce injection, drug splitting, and sex risk, and by teaching communication skills to conduct outreach to personal risk network members. The intervention consisted of five group-based sessions, one individual session, and one dyad session with a risk network member.
Other names: STEP into action
The control condition focused on injection drug-use related topics (e.g. HIV testing, Hepatitis C and drug overdose). The sessions were educational and did not include skills training. The control condition consisted of five group-based sessions.
Time frame: 6 months
Time frame: 6 months
Time frame: 6 months
Time frame: 6 months
Time frame: 12 months
Time frame: 12 months
Time frame: 12 months
Time frame: 12 months
Time frame: 18 months
Time frame: 18 months
Time frame: 18 months
Time frame: 18 months
Time frame: 18 months
Time frame: 18 months
Time frame: 18 months
Johns Hopkins Bloomberg School of Public Health
Other
A Network & Dyad HIV Prevention Intervention for IDU's
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01725815
Arterial Occlusive Diseases, Arteriosclerosis
Atlanta, Georgia, United States
View Trial DetailsNCT02126696
Alcohol-Related Disorders, Alcoholism
Butha-Buthe, Lesotho
View Trial DetailsNCT00300209
Digestive System Diseases, HIV
New York, United States
View Trial DetailsNCT01645033
Chemically-Induced Disorders, Digestive System Diseases
Hartford, Connecticut, United States
View Trial Details